Are you Dr. Gordon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 34 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2811 Wilshire Blvd
Suite # 414
Santa Monica, CA 90403Phone+1 323-669-2121Fax+1 323-660-7128- Is this information wrong?
Summary
- Dr. Erlinda Gordon, MD is a pediatric hematologist/oncologist in Santa Monica, California. She is currently licensed to practice medicine in California and Ohio. She is an Associate Professor at USC School of Medicine.
Education & Training
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalFellowship, Pediatric Hematology/Oncology, 1976 - 1978
- The MetroHealth System/Case Western Reserve UniversityResidency, Pediatrics, 1974 - 1976
- The MetroHealth System/Case Western Reserve UniversityResidency, Pathology-Anatomic and Clinical, 1973 - 1974
- St Alexis HospitalInternship, Transitional Year, 1972 - 1973
- University of Santo TomasClass of 1971
Certifications & Licensure
- CA State Medical License 1990 - 2024
- OH State Medical License 1979 - 1996
Clinical Trials
- SAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue Sarcoma Start of enrollment: 2017 Apr 13
- Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers Start of enrollment: 2017 Aug 24
- Expanded Access for DeltaRex-G for Osteosarcoma, Chondrosarcoma, Soft Tissue Sarcoma, Pancreas and Breast Cancer
Publications & Presentations
PubMed
- Phase II Trial ofSirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update.Ganjoo, K., Van Tine, B., Chugh, R., Hornick, J., Du, H., Ding, L., Schmid, A., Navarro, W., Kwiatkowski, D., Wagner, A., Ravi, V., Riedel, R., Cranmer, L., Gordon, E....> ;Journal of Clinical Oncology. 2024 Mar 1
- From Mendel to Gene Therapy.Samantha L Jeffrey, Don A Brigham, Sant P Chawla, Noah Federman, Frederick L Hall, Erlinda M Gordon> ;Anticancer Research. 2023 Oct 1
- 2 citationsEarly-stage+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, aInhibitor.Sant P Chawla, Olga Olevsky, Geeta Iyengar, Don A Brigham, Sonu Thomas, Kushal Suryamohan, Leland Foshag, Frederick L Hall, Erlinda M Gordon, Nadezhda Omelchenko> ;Anticancer Research. 2023 Jun 1
- Join now to see all
Press Mentions
- Boy, 11, with Rare Stage 4 Cancer Moves to SoCal to Receive Experimental TreatmentSeptember 30th, 2021
- Family of 11-Year-Old with Cancer Seeks to Raise $500K for Treatment in Santa MonicaSeptember 22nd, 2021
- Deltarex-G Gains Fda Authorization as Adjuvant Therapy for Early-Stage Triple Negative Metaplastic Breast CancerJune 28th, 2021
- Join now to see all